FCM
Farallon Capital Management’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $122K | Hold |
17,000
| – | – | ﹤0.01% | 122 |
|
|
2025
Q1 | $102K | Hold |
17,000
| – | – | ﹤0.01% | 130 |
|
|
2024
Q4 | $133K | Hold |
17,000
| – | – | ﹤0.01% | 131 |
|
|
2024
Q3 | $184K | Sell |
17,000
-408,161
| -96% | -$4.41M | ﹤0.01% | 139 |
|
|
2024
Q2 | $3.58M | Sell |
425,161
-36,839
| -8% | -$311K | 0.02% | 90 |
|
|
2024
Q1 | $3.1M | Buy |
462,000
+445,000
| +2,618% | +$2.99M | 0.01% | 104 |
|
|
2023
Q4 | $100K | Hold |
17,000
| – | – | ﹤0.01% | 134 |
|
|
2023
Q3 | $166K | Sell |
17,000
-966,452
| -98% | -$9.42M | ﹤0.01% | 131 |
|
|
2023
Q2 | $11.6M | Hold |
983,452
| – | – | 0.06% | 87 |
|
|
2023
Q1 | $10.6M | Buy |
983,452
+898,313
| +1,055% | +$9.69M | 0.06% | 96 |
|
|
2022
Q4 | $984K | Sell |
85,139
-160,000
| -65% | -$1.85M | 0.01% | 172 |
|
|
2022
Q3 | $3.66M | Sell |
245,139
-754,861
| -75% | -$11.3M | 0.02% | 189 |
|
|
2022
Q2 | $9.02M | Buy |
1,000,000
+150,000
| +18% | +$1.35M | 0.05% | 141 |
|
|
2022
Q1 | $6.37M | Buy |
850,000
+250,000
| +42% | +$1.87M | 0.03% | 171 |
|
|
2021
Q4 | $5.15M | Hold |
600,000
| – | – | 0.03% | 178 |
|
|
2021
Q3 | $5.05M | Hold |
600,000
| – | – | 0.02% | 179 |
|
|
2021
Q2 | $4.87M | Hold |
600,000
| – | – | 0.02% | 183 |
|
|
2021
Q1 | $5.27M | Hold |
600,000
| – | – | 0.03% | 180 |
|
|
2020
Q4 | $6.74M | Buy |
+600,000
| New | +$6.74M | 0.04% | 113 |
|